Available on Snowflake Marketplace, Digityze AI combines advanced machine learning, biophysics-informed models, and visual AI to organize complex manufacturing documents, including PDFs, handwritten notes, tables, forms, and fragmented data, unlocking critical insights
By
Katalyze AI
6
min read
Built for biopharmaceutical and other highly-regulated industries, Digityze AI is an integration of generative AI, raw material characterization, and large language models that automates the extraction, validation and approval of data buried in complex documents such as Certificates of Analysis (CoAs), batch records, SOPs, lab reports and any other document type specific to the organization’s needs. With modular workflows and support for human oversight, the platform enables teams to achieve both high accuracy and auditability.
“Pharmaceutical manufacturers are under immense pressure to streamline their processes, reduce waste and improve output, all while maintaining stringent regulatory compliance,” said Reza Farahani, CEO, Katalyze AI. “By launching Digityze AI on Snowflake, we’re making it easy for life science companies to extract critical data from buried documents and put it to use across their AI workflows, securely, at scale and in real time.”
“Katalyze AI’s commitment to helping Snowflake empower every enterprise to achieve its full potential through data and AI can be seen through the launch of Digityze AI,” said Shannon Katschilo, Country Manager of Canada, Snowflake. “We look forward to driving deeper value for Snowflake’s AI Data Cloud ecosystem by delivering enhanced value to customers in highly-regulated industries through streamlined data insights, rapid analytics capabilities, and enterprise-scale AI solutions.”
About Katalyze AI
Katalyze’s AI platform improves yield, traceability, and cycle time across biopharma manufacturing processes. With Katalyze AI, Design, Optimize and Automate Your Bioprocesses at scale.